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ABSTRACT 
The aim of this study was to demonstrate the sensitivity of Optical coherence tomography (OCT) in detection of 
geographic atrophy (GA) secondary to exudative age related macular degeneration (AMD). In this retrospective case 
series study 77 patients (53% female, with mean ± standard deviation [SD] of 82.6±9.3 years) with 97 eyes (45 OS [left 
eyes]/52 OD [right eyes]) were included. This was a retrospective review of the charts of patients who presented with 
exudative AMD at the Pitié Salpetrière Hospital, Paris, France, between December 2016 and August 2017 that received 
intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) therapies. At baseline, following 
biomicroscopy examination, multimodal imaging was performed including, fluorescein angiography (FA), fundus auto-
fluorescence (FAF), spectral domain optical coherence tomography (SD-OCT) and indocyanine green angiography (ICGA). 
During the follow-up, SD-OCT with/without FAF and FA were performed for each patient at 6, 12 and 18 months. For 
investigation of the prevalence of GA in eyes undergoing intravitreal injections with anti-VEGF therapy, FAF and SD-OCT 
images were qualitatively reviewed by four independent observers (two graders per group). Kappa coefficient of Cohen 
was calculated to determine agreement between the graders. The kappa coefficient of Cohen, for inter-rater agreement 
in the evaluation of FAF images was 0.468, indicating a moderate agreement between the first and second raters. Thus, 
the sensitivity and specificity of FAF for the diagnosis of GA were 70% and 57%, respectively. If atrophy was assessed 
with SD-OCT image analysis, the kappa coefficient for inter-rater agreement was 0.846, implying an acceptable 
agreement between both readers. The sensitivity and specificity of SD-OCT were 93% and 58% respectively. In 
conclusion, SD-OCT image analysis was more sensitive than FAF for identifying GA in patients treated for exudative AMD. 
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INTRODUCTION
Age-related macular degeneration (AMD) is the main 
reason for blindness after 50 years of age [1] and is a 
phenotypical heterogeneous disease that includes dry 
(atrophic) and wet (exudative) forms. The wet form is 
characterized by an unusual choroidal neovascularization 
(CNV) in the macula [2]. The Anti-vascular endothelial 
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growth factor (Anti-VEGF) has been successful in 
improving visual prognosis of patients with neovascular 
age-related macular degeneration (nAMD) and other wet 
(exudative) retinal Conditions by intravitreal injection [3]. 
There are three anti-VEGF agents currently used globally 
including Ranibizumab (Lucentis; Genentech, Inc., South 
San Francisco, CA, USA), Aflibercept (Eylea; Regeneron 
Pharmaceuticals, Inc., Tarrytown, NY, USA) and 
Bevacizumab (Avastin; Genentech, Inc.). In France, 
however, the regulatory authorities prevent the off-label 
usage of Bevacizumab in ophthalmology procedure [4], 
and hence only Ranibizumab and Aflibercept are 
available. Moreover, both these drugs are administered 
for all patients in France and choosing between these 
drugs is independent of economic considerations or 
patients’ affiliation with insurance agencies. The safe 
usage and frequency of Bevacizumab and Ranibizumab 
treatment of macular degeneration related to nAMD was 
uncertain, hence, the purpose of the IVAN clinical trial in 
the United Kingdom was to undertake the hindrance of 
VEGF in CNV [5]. In the USA, the most popular trial, 
Comparison of Age-related macular degeneration 
Treatments Trial (CATT) was designed as a substitute [6]. 
The 2-year CATT [7] reports portrayed the differences 
and similarities between drugs and the process of 
treatment to develop a new geographic atrophy (GA) in 
the eye under study during the follow-up. There were no 
differences among the drugs in IVAN trial compared with 
the CATT and IVAN data combined. Moreover, our 
detailed study showed a high and steady increase in the 
risk of getting a new GA with injections in monthly basis 
compared to intermittent treatment. It was a concern 
that any benefit from monthly treatment may not be 
maintained in the longer term [8]. 
Geographic atrophy secondary to AMD has the key 
characteristics of progressive augmentation of these 
spots of retinal atrophy, which includes the outer retina, 
choroid and retinal pigment epithelium (RPE) [2]. For 
prevention of GA development, there is no treatment at 
the moment. In the recent times, Fundus 
Autofluorescence (FAF) has been used to follow GA 
progression in a multicenter natural history study 
entitled “Fundus Autofluorescence Imaging in Age-
Related Macular Degeneration (FAM)” [9, 10]. The FAF 
imaging allows topographical mapping of distribution of 
lipofuscin (LF) in the monolayer RPE, in the outer retina 
and sub-neurosensory space [11, 12]. This imaging 
provides additional information that cannot be obtained 
using other modalities such as fluorescein angiography 
(FA), or spectral-domain optical coherence tomography 
(SD-OCT) and fundus photography. Color fundus 
photography is widely used for the measurement of the 
size of GA areas in the epidemiologic and natural history 
studies [4, 6]. Nevertheless, color fundus photography 
has several shortcomings in the determination of GA 
primarily to interpatient variations of fundus 
pigmentation and variations of drusen appearance. The 
FAF is predominantly used in everyday clinical practice. It 
is a noninvasive imaging method and depends on retinal 
fluorophores LF, which accumulates with aging RPE post-
phagocytosis [7, 8]. The FAF uses an excitation 
wavelength of 488 nanometer (nm) and bandwidth for 
emission in the range of 500-700 nm. The imaging has 
been successful especially for various aspects in GA 
secondary to AMD. In atrophic areas of the macula, there 
is a loss of RPE cells due to loss of intrinsic LF 
fluorophores. The GA areas exhibit low to dark FAF 
signals (zero), with a huge difference among the area of 
atrophy and perilesional retina [13]. Thus, using SD-OCT 
imaging, choroidal signal enhancement due to loss of 
absorbing pigment and thinning of the outer retinal 
layers such as the outer nuclear layer is evident at the 
site of GA while these findings are often corresponded to 
a lower FAF signal. SD-OCT showed also a hypo intensity 
for lesions above RPE, as fibro-glial lesion. In Seven-up 
study, [14] evaluation of the presence of GA was 
based on the FAF. However, both the GA and fibrosis are 
hypo-autofluorescence lesions which might be 
challenging to be differentiated (Figures 1 and 2). Thus, 
the main goal of our study was to understand and 
differentiate detection of GA assessed by SD-OCT or FAF 
in patients treated for an exudative AMD developing 
secondary GA (Figure 3). 
METHODS 
A retrospective review was performed on patients’ 
charts presented with exudative AMD at the Pitié 
Salpetrière Hospital, Paris, France, between December 
2016 and August 2017 who received anti-VEGF by 
intravitreal injection. At baseline, following 
biomicroscopy examination, multimodal imaging was 
performed including FA, FAF, Spectralis HRA+SD-OCT 
(Heidelberg Engineering, Heidelberg, Germany) and 
indocyanine green angiography (ICGA). While the follow-
up treatment period, SD-OCT with or without FAF and FA 
were performed in each patient at 6, 12 and 18 months. 
The FAF and SD-OCT images were qualitatively reviewed 
by four independent observers (two readers per group) 
to determine whether GA was present. In accordance 
with the tenets of the Declaration of Helsinki, a written 
informed consent was obtained from each participant. 
For data review, the approval of French Society of 
Ophthalmology Ethics Committee was taken. The 
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inclusion criteria were; 1) patients with exudative AMD 
as evaluated with fundus biomicroscopic and FA, FAF, 
ICGA at baseline, 2) treatment with anti-VEGF intravitreal 
injection (at least 6 injections during the follow-up 
period). 
 
 
Figure 1: Patient 1 – Left eye of a 65-year-old female patient with exudative Age related macular degeneration (AMD). A: Fundus auto-fluorescence 
(FAF) showed a large macular lesion hypo auto-fluorescence surrounded by a halo hyper auto-fluorescence. B: Spectral-domain optical coherence 
tomography (SD-OCT), showed a homogeneous lesion localized above the RPE. The hypo auto-fluorescence lesion is a fibrosis without retinal pigment 
epithelium (RPE) atrophy lesion. 
 
 
Figure 2: Patient 2- Right eye; a 74-year-old female patient presented with exudative age related macular degeneration (AMD) and received 21 
intravitreal injection of anti-vascular endothelial growth factor (Anti-VEGF). A: Fundus auto-fluorescence (FAF) showed a hypo auto-fluorescence lesion 
on the macula surrounding by a hyper auto-fluorescence in the temporal superior of the lesion. B: Spectral-domain optical coherence tomography (SD-
OCT) showed homogeneous lesion localized above the RPE with a thinning of the pigment epithelium, and the outer retina layer, next to the fovea. The 
lesion corresponding to a fibrosis associated with atrophy of the retinal pigment epithelium (RPE). 
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Figure 3: Patient 3- A 70-year-old male patient with exudative age related macular degeneration (AMD) on the right eye who received 5 intravitreal 
injections of anti-vascular endothelial growth factor (Anti-VEGF). Initially, he had an atrophic lesion before the treatment. A: Fundus auto-fluorescence 
(FAF) showed a large macular lesion hypo auto-fluorescence surrounded by a hyper auto-fluorescence halo. B: Spectral-domain optical coherence 
tomography (SD-OCT), of the same eye showed thinning of the retina pigment epithelium (RPE), and the outer retina layer, next to the fovea. The 
lesion is atrophic despite their different outliner, all lesions are hypo auto-fluorescence, which makes easier the diagnosis of geographic atrophy (GA), 
but the SD - OCT confirms precisely the difference between the atrophic lesion (Fig 3) versus Fibrosis associated with GA (Fig 2) and the fibrosis (Fig 1). 
 
Only, patients who developed GA during anti-VEGF 
treatment were included in the study. Patients with CNV 
because of causes other than AMD such as inflammatory 
disease or other retinopathies (including diabetic 
retinopathy and retinal venous occlusion) were excluded. 
The FAF images were received using a short wavelength 
(488 nm). This imaging modality has been shown to 
provide an adequate assessment of atrophy and 
currently considered the best available tool to define 
areas of RPE loss [15]. As per our clinical standards, at 
first treatment consisted of a series of three intravitreal 
injections of anti-VEGF performed by a retinal specialist 
using established techniques. This protocol comprised of 
three initial injections (monthly installments) based on 
Pro ReNata regiment (PRN) [16] decision to withdraw or 
not in the advancement of visual acuity (VA) and 
presence or absence of sub-fovea fluid as seen by OCT. 
After the initial treatment, for every subsequent 
month, patients underwent a lengthy medical and ocular 
analysis, procedure of corrected distance visual acuity 
(CDVA) with the help of the Early Treatment Diabetic 
Retinopathy Study (ETDRS) charts and ophthalmic 
assessment, which consists of a slit-lamp bio-microscopic 
examination, intraocular pressure (IOP) measurement, 
fundus bio-microscopic, SD-OCT examination, FAF and 
FA. So as to investigate the prevalence of GA in eyes that 
received intravitreal injections of anti-VEGF, FAF images 
from the last follow-up exam was qualitatively reviewed 
by two independent observers (AS and NB) (appearing as 
hypofluorescent regions on FAF). In cases of discordance 
between the two graders, a third senior grader (NM) 
opinion was required. Similarly, two readers (NB and VC) 
analyzed SD-OCT images and in cases of discrepancy 
between them a third senior grader (NM) resolved it. 
Statistical analysis was performed using SPSS version 
22.0 (IBM Corp, Amont NY, USA). All values were 
expressed as mean ± Standard deviation (SD). Data 
analysis was performed using Wilcoxon signed rank to 
analyze the SD values between different batches. A P 
value less than 0.05 was considered statistically 
significant. Interclass correlation coefficient (ICC) was 
used to assess agreement of measurements between the 
readers. 
RESULTS 
Initially, 119 eyes of 97 consecutive patients (55 females 
and 42 males) were selected. Of these, 22 eyes of 20 
patients were excluded (six eyes of 6 patients imaged by 
TOPCON, 12 eyes of 12 patients did not have FAF and 4 
eyes of 2 patients had low quality of images). Overall, 97 
eyes (45 left eye [OS] versus 52 right eye [OD]) of 77 
patients with mean ± SD age of 82.6± 9.3 years (range, 
94-67) were considered in the experimental analysis 
(Table 1). Inter-agreement of FA between the readers 
were 0.464 and 0.846 for SD-OCT. The sensitivity and 
specificity of the FAF analysis for the diagnosis of GA 
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were 70% and 57%, respectively, suggesting a modest 
rate for both and, the kappa coefficient for inter-rater 
agreement was 0.46, implying moderate agreement 
among readers. However, when GA was assessed using 
SD-OCT image analysis, the kappa coefficient for inter-
rater agreement was 0.8, implying as an almost perfect 
agreement between both readers. Even though, the 
sensitivity was 93%, indicating a low rate of false 
negatives; however, the specificity was 58%, suggesting a 
modest rate of false positives with SD-OCT (Table 2). 
These results showed that SD-OCT image analysis is more 
sensitive and accurate than FAF for identifying GA in 
patients being treated for exudative AMD. Using both 
methods of analysis may significantly improve the 
accurate diagnosis of GA in patients with AMD. 
 
Table 1. Demographic Characteristics of the Study Participants 
Characteristics of the Participants (Total: 97 eyes; 77 patients) 
Laterality of Subjects’ Eye (n) 52 OD  45 OS  
Gender (n) 41 M  36 F  
Age (Y) Mean ± SD M=79.7±11.07 F=82.6±9.3 
Abbreviations: n: number; OD: right eye; OS: left eye; M: male; F: female; SD: standard deviation. 
 
Table 2. Strength of Agreement Using SD-OCT and FAF Between Two Readers 
 Clinical Features of SD-OCT and FAF  
Imaging Methods  Sensitivity Specificity ICC Strength of Agreement (Altman’s Kappa Benchmark Scale) 
FAF 70% 57% 0.464(0.434-0.506) Moderate 
SD-OCT 93% 58% 0.846(0.811-0.918) Very Good 
Abbreviations: %: percentage; ICC: The Intraclass Correlation Coefficient; SD-OCT: spectral domain optical coherence tomography; FAF: Fundus autofluorescence. 
 
DISCUSSION 
In this cross-sectional study, we investigated GA in AMD 
eyes previously treated with anti-VEGF and with absence 
of neovascular activity (no sub-retinal hemorrhage, a sign 
of fluid in or under the retina and no treatment for at 
least 6 months). We found that eyes with evidence of 
fibrovascular scar are characterized by a worse structural 
and functional impairment. The GA is normally, specified 
as an acute circumscribed surface of RPE atrophy 
through which choroidal vessels can be viewed. Notably, 
we used the FAF and SD-OCT imaging to distinguish eyes 
with excessive increase in the fibrous component, which 
characterizes a fibrocellular scar phenotype. 
AMD is one of the most common reasons for blindness 
which is irreversible in elderly in highly developed 
countries [17] and includes two forms of wet (exudative) 
and dry (atrophic) AMD. RPE dysfunction disrupts both 
photoreceptors and choroidal vasculature; this tissue 
disruption leads to tissue atrophy and 
neovascularization. Histologically, the exudative lesion is 
a complex structure composed of different constituents, 
including blood vessels, macrophages, myofibroblasts 
and fibroblasts [18, 19]. Although the pathogenic 
sequence leading to macular fibrosis in neovascular AMD 
is still not well understood, Ishikawa et al. thought that it 
could be based on a complex tissue repair mechanism 
[20]. However, Dry (atrophic) AMD has the 
characteristics of a progressive course to degeneration of 
photoreceptors and RPE. It is identified by a loss of the 
outer neurosensory retina, the thinning of RPE and the 
choriocapillaritis. Hence, both atrophic and advance of 
exudative AMD forms lead to damage and death of 
photoreceptors. As noted above FAF imaging permits 
topographical connection between distribution of LF in 
the RPE and mapping of other fluorophores that might 
happen with the disease in the outer retina, and the 
sub neuro-sensory space [21, 22]. Due to absence of RPE 
cells and reduction of intrinsic LF fluorophores, atrophic 
areas in patients with GA exhibit a severely reduced 
signal (dark). Therefore, in advanced form of exudative 
AMD, changes due to photoreceptors loss, increase of 
melanin and presence of scar could probably block the 
fluorophores induced by the FAF (Dark).  
The main goal of our study was to distinguish detection 
of GA assessed by SD-OCT or FAF in patients treated for 
an exudative AMD developing secondary GA. In our 
retrospectively study, we reviewed charts of patients 
with exudative AMD who received intravitreal anti-VEGF 
injections during follow-up examinations. Patients with 
FAF and SD-OCT images taken in the follow-up process 
were considered in the analysis to identify GA. We found 
that sensitivity and specificity of the FAF analysis for the 
diagnosis of GA were 70% and 57%, respectively, 
suggesting a modest rate for both. However, when 
atrophy was assessed using SD-OCT image analysis, the 
kappa coefficient for an inter-rater agreement was 0.8, 
implying that the agreement between both readers was 
almost perfect.  
Several studies have demonstrated the apoptotic loss of 
the RPE as a necessary last stage symptom of severe 
AMD [23]. The authors also confirmed that ARPE-19 cells, 
a widely accepted RPE cell line, displayed necrotic 
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features consisting of poly (ADP-ribose) polymerase-1 
(PARP-1) activated by hydrogen peroxide (H2O2). They 
reported that apoptosis-inducing factor (AIF) - 
independent PARP - 1 - dependent necrosis creates a 
primary mechanism of RPE cell loss, thus cause a retinal 
degeneration in case of a severe AMD. Moreover, Du. J et 
al. [24] demonstrated in their recent study that reductive 
carboxylation capacity in RPE overshoots all other tested 
cells, not limited to retina, glial cells, neural tissue and a 
cancer cell line. Loss of reductive carboxylation damages 
redox balance and dramatically heightens RPE sensitivity 
to oxidative damage, proposing that shortcomings of 
reductive carboxylation might stimulate RPE cell loss. By 
analyzing their study, we concluded that the glial cells 
had also a reductive carboxylation and lead to cell death 
[24]. Therefore, we can conclude that RPE is the 
predilection site for cell death in retinal pathologies [25], 
particularly severe and dry AMD, but the elements in this 
process to death are independent. Without speculated, it 
is considered that the cell death would cause hypo-
fluorescence phenome visualized in FAF in atrophy form 
or advanced AMD. With SD-OCT, the atrophy form 
reveals choroidal hyperreflectivity behind the RPE 
reduction of the photoreceptor layer. Both the 
quintessential findings in GA and fibrosis appear as a 
compact hyper-reflective component located in the sub-
RPE or the sub-retinal compartment, and it was 
demonstrated that it could be more frequent than RPE 
atrophy [26]. CATT study group [7] (two years) used both 
the FA and the SD- OCT in the follow-up period, because 
the authors found that there might be numerous 
anatomical observations identified only on SD-OCT. The 
authors believed that the fluorescence blocked on FA 
corresponded to a particular area of hypofluorescence, 
which is contiguous to the CNV and generally, not 
influenced by visible hemorrhage, pigmentation or other 
conditions observed on the color photography. The 
wedge of fluorescence could represent a fibrosis after 
advance stage of the nAMD or atrophic form [7]. In the 
context of differential diagnosis of atrophy in FAF, 
including scotoma, metamorphosis, adult-onset 
vitelliform dystrophy is a common adult disease. This 
frequent pathology presents itself in FA like CNV type 2. 
Bhakhri R et al. [27] in their case report demonstrated 
the importance of SD-OCT and FAF in differential 
diagnosis. The authors described FAF atrophy as a 
hypoautofluorescent central lesion surrounded by a 
hyper autofluorescent,  which could be an accumulation 
of photoreceptor debris, pigment granules (hypo 
autofluorescent) and LF (hyper autofluorescent ). In SD-
OCT, the diagnosis already showed an empty space 
between the RPE and photoreceptors indicative of a 
sensory retinal detachment. 
Choroidal melanocytic is a benign tumor caused by 
proliferation of the melanocytes normally found in the 
uvea. Singh AD et al. [28], have shown the importance of 
the FAF combined with SD-OCT in clinical practice sets 
and for the detection of prognostic factors. Authors 
compared detection rates of drusen and subretinal fluid 
by fundus photographs with high-definition Fourier-
domain optical coherence tomography (FD-OCT) and that 
of orange pigment by FAF in patients with indeterminate 
choroidal melanocytic lesion (IML) (categorized as small 
tumor). Their findings indicated that changes in small 
melanoma range from chronic changes such as drusen 
and thinning of the retina, subretinal fluid that overlaps 
with those observed in nevus and melanoma. We 
believed that both exams are noninvasive and important, 
but they should be coupled for a better diagnosis. Our 
result corroborated to Holz et al. [29], who demonstrated 
the advantage of combining SD-OCT and FAF confocal 
scanning laser ophthalmoscope imaging for GA 
assessments. 
We agree with Chen Q et al. [30], who improved 
visualization technique of GA in SD-OCT images and a 
new semi-automated GA segmentation method. They 
emphasized the advantage of developing GA 
segmentation and quantification techniques in SD-OCT 
images over other modalities. The authors attested that 
the images in FAF are the result of an in-depth 
integration, superimposing different retinal structures. 
These images may overestimate or underestimate 
certain pathologies. Hence, pairing FAF with the SD-OCT 
and certifying it as the gold standard in GA has been 
matter of interest.  
Our study had several limitations, primarily due to the 
retrospective nature of imaging analysis, monocentric 
aspect and lack of measurement and analysis of atrophy 
on FAF at baseline and during the follow-up. Analysis on 
FAF was not used because we did not prove the need of 
measurement and VA measurement between fibrosis 
lesion and GA undergoing AMD. Further, prospective and 
multicentric investigations are necessary to reconfirm 
our hypothesis. Studies of a small number of subjects can 
be easy to conduct by analyzing patient records and 
images by ophthalmologists specialist in retinal imaging. 
Therefore, an obvious strength is that the research can 
be addressed in a relatively short period. Obtaining 
ethical and institutional approval is easier in small studies 
than large multicenter studies. It is often accurate to test 
a new research hypothesis with a small number and 
generate a hypothesis, rather than a large multicentric 
 
 
Med Hypothesis Discov Innov Ophthalmol. 2019; 8(4)  
304 FUNDUS AUTOFLUORESCENCE COMBINED WITH OCT FOR DIAGNOSE OF GEOGRAPHIC ATROPHY  
confirmation study. Thus, as, being a retina specialist 
specialized in AMD, our discussions led us to conclude 
that the FAF alone was not enough strong for the 
diagnosis of GA. Hence, SD-OCT combined with FAF was a 
better approach for diagnosing and monitoring patients 
with atrophic and exudative AMD. Another strong point 
was to have a Spectralis HRA, which had FAF and SD-OCT 
on the same imaging device. 
CONCLUSIONS 
SD-OCT image analysis is more sensitive than FAF for 
identifying GA in patients treated for exudative AMD. 
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